Equity
€5.4m ▲ 7.8%
DRBP has made a profit in every financial year since 2013.
DRBP
Lifetime
13 annual accounts with figures on one time axispeak €1.4m (2023)
€997,788▼ 5.2%
peak €964,191 (2023)
€718,959▼ 1.7%
peak €5.4m (2025)
€5.4m▲ 7.8%
€232,326▲ 74.2%
peak 0 FTE (2022)
-not published
Board1 name since 2013
1 director
Documentsfilings and deeds
06-07-202625 days before the deadline
2025abbreviated format
Dividend €322,848Debts from €133,374 to €232,326Cash from €245,404 to €557,795
Key points
from the 2025 annual accountsTurnover
≈ €1.5m estimated
The accounts state no turnover.
Debts
€232,326 ▲ 74.2%
Debts rose by €98,952 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
24.08 was 38.28 in 2024
Short-term debts rose from €133,374 to €232,326.
Filings
13 annual accounts since 2013
Three of the last ten came late. The 2016 accounts came latest: 30 days after the end of the period.
Position in the sector
€718,959
Higher net result than 95% of companies in human health. Sector median €125,318 · 2,768 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as DRBP has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for DRBP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0502692701
Company renamed from DOKTER ,KLINISCH BIOLOOG to DRBP
Appointment: (director) · “De uitoefening van de geneeskunde,meer bepaald de KLINISCHE BIOLOGIE,door de geneesheren-aandeelhouders in…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 14-10-2022 · Gazette deed
Registered office moved from Zandhoven to Zonhoven
New registered office: Grote Hemmenweg 48 te 3520 Zonhoven · Previous registered office: Vogelzandstraat 51, 2240 Zandhoven · Gazette deed
Director in office: (manager)
Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DRBP Zonhoven | €5.6m | €1.0m | 95.8% | - |
| DR SEBASTIEN ONGENA - MKA CHIRURG Schilde | €5.9m | €1.0m | 43.1% | - |
| Docteur Lenfant Cabinet Ophtalmologique Mouscron | €4.8m | €1.0m | 42.1% | 1 |
| Dr. K. Van Pelt Heusden-Zolder | €4.7m | €1.0m | 83.7% | 0 |
| Dr. Guy Missotten Hasselt | €4.8m | €0.8m | 67.1% | 2.4 |
| ONAMIA Keerbergen | €4.8m | €0.9m | 48.1% | 0.7 |
| DOCTEURS KOCH - PIENS , OPHTALMOLOGIE Woluwe-Saint-Lambert | €4.6m | €1.1m | 70.6% | 2.5 |
These companies have the same main activity as DRBP: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €4.6m and €5.9m, founded between 2009 and 2015.
Official details
Source: KBO- Status
- Active since 23-01-2013Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.215.943.1253520 Zonhoven, registered on 23-01-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 09-10-2024
Annual accounts 2025
- €5.6m▲ 9.6%
- Filing
- Filed on 06-07-2026, 25 days before the end of the filing period
Insights on DRBP
DRBP files the abbreviated format. That format states no turnover. The gross margin rose from €54,424 in 2013 to €997,788 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DRBP
- What is the company number of DRBP?
- The company number of DRBP is 0502.692.701. The VAT number is the same number with BE in front: BE 0502.692.701.
- Where is DRBP based?
- The registered office is at Grote Hemmenweg 48, 3520 Zonhoven.Company details
- What does DRBP do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DRBP?
- DRBP is a private limited company (BV).
- When was DRBP founded?
- DRBP was founded on 23-01-2013.
- Is DRBP still active?
- Yes, DRBP is an active enterprise in the KBO register.
- What is the turnover of DRBP?
- The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €997,788 and 31 comparable companies (NACE 86220). It probably lies between €1.3m and €2.1m.Financials
- Is DRBP profitable?
- In financial year 2025, DRBP made a profit of €718,959.
- Where can I find the annual accounts of DRBP?
- DRBP filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DRBP due?
- DRBP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.